<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>83(12)</volume><submitter>Hernandez PV</submitter><pubmed_abstract>We examined the correlation between class I HLA evolutionary divergence (HED), a surrogate for the capacity to present different peptides, and the outcomes of 234 adult inpatients with confirmed SARS-CoV-2 infection. Genomic DNA was extracted from peripheral blood and genotyped by next-generation sequencing (NGS). HED scores for HLA class I (HLA-A, -B, and -C) genotypes were calculated using Grantham's distance. Higher HED scores for HLA-B, but not HLA-A or -C, are significantly associated with a decreased probability of poor outcomes including ICU admission, mechanical ventilation, and death (OR = 0.93; P = 0.04) in the univariate analysis. In the multivariate analysis, increased HLA-B HED score, younger age, and no comorbidity were independently associated with favorable outcomes (P = 0.02, P = 0.01, and P = 0.05, respectively). This finding is consistent with the notion that broader peptide repertoires presented by class I HLA may be beneficial in infection control.</pubmed_abstract><journal>Human immunology</journal><pagination>803-807</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9464580</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection.</pubmed_title><pmcid>PMC9464580</pmcid><pubmed_authors>Duffy B</pubmed_authors><pubmed_authors>Hernandez PV</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Hock K</pubmed_authors><pubmed_authors>Farnsworth C</pubmed_authors><pubmed_authors>Schindler E</pubmed_authors></additional><is_claimable>false</is_claimable><name>HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection.</name><description>We examined the correlation between class I HLA evolutionary divergence (HED), a surrogate for the capacity to present different peptides, and the outcomes of 234 adult inpatients with confirmed SARS-CoV-2 infection. Genomic DNA was extracted from peripheral blood and genotyped by next-generation sequencing (NGS). HED scores for HLA class I (HLA-A, -B, and -C) genotypes were calculated using Grantham's distance. Higher HED scores for HLA-B, but not HLA-A or -C, are significantly associated with a decreased probability of poor outcomes including ICU admission, mechanical ventilation, and death (OR = 0.93; P = 0.04) in the univariate analysis. In the multivariate analysis, increased HLA-B HED score, younger age, and no comorbidity were independently associated with favorable outcomes (P = 0.02, P = 0.01, and P = 0.05, respectively). This finding is consistent with the notion that broader peptide repertoires presented by class I HLA may be beneficial in infection control.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2024-11-09T15:43:28.384Z</modification><creation>2024-11-09T15:43:28.384Z</creation></dates><accession>S-EPMC9464580</accession><cross_references><pubmed>36109290</pubmed><doi>10.1016/j.humimm.2022.09.004</doi></cross_references></HashMap>